Research Article
High Prevalence of Metabolic Syndrome in Patients with Discoid Lupus Erythematosus: A Cross-Sectional, Case-Control Study
Table 1
Comparison of sociodemographic features, medical history findings, and metabolic syndrome components in study subjects.
| | Characteristics | DLE () | Controls () | value |
| | Age, years, mean ± SD | | | 0.911 | | Gender, (%) | | | | | Male | 18 (30) | 25 (30.5) | 0.950 | | Female | 42 (70) | 57 (69.5) | | | Current smokers, (%) | 34 (56.7) | 26 (31.7) | | | Packet/year | | | | | Medical history, (%) | | | | | Diabetes mellitus and/or antidiabetic use | 6 (10) | 9 (11) | 0.852 | | Hypertension and/or antihypertensive use | 18 (30) | 14 (17.1) | 0.069 | | Hyperlipidemia/dyslipidemia and/or antihyperlipidemic use | 4 (6.7) | 1 (1.2) | 0.162 | | Cardiovascular disease | 5 (8.3) | 4 (4.9) | 0.494 | | Depression and/or anxiety | 24 (40) | 7 (8.5) | | | Body mass index, mean ± SD | | | 0.385 | | Dyslipidemia (%) | 40 (66.7) | 38 (46.3) | | | Metabolic syndrome | 29 (48.3) | 20 (24.4) | | | Increased waist circumference ≥ 94 cm (male) or ≥80 cm (female) | 38 (63.3) | 49 (59.8) | 0.666 | | Hypertriglyceridemia ≥ 150 mg/dL or antihyperlipidemic treatment | 26 (43.3) | 18 (22.0) | | | Reduced HDL-cholesterol < 50 mg/dL (female) or <40 mg/dL (male) | 37 (61.7) | 19 (23.2) | | | Elevated blood pressure ≥ 130/85 mmHg or antihypertensive treatment | 25 (41.7) | 26 (31.7) | 0.222 | | Increased fasting blood glucose ≥ 100 mg/dL or hypoglycemic treatment | 20 (33.3) | 22 (26.8) | 0.402 | | Number of metabolic syndrome components | | | |
|
|
Statistically significant values.
|
